Literature DB >> 6476209

Penicilliosis marneffei in Thailand: report of five human cases.

P Jayanetra, P Nitiyanant, L Ajello, A A Padhye, S Lolekha, V Atichartakarn, P Vathesatogit, B Sathaphatayavongs, R Prajaktam.   

Abstract

The first two cases of Penicillium marneffei infection in humans were reported in 1959 and 1973. There had been no additional clinical reports of penicilliosis marneffei, until the five new cases of human infection described in this paper, the first from Thailand. The patients, three of whom died, came from various parts of the country. Their common clinical manifestations were fever and generalized lymphadenopathy, with multiple soft tissue, bone, joint and pulmonary involvement. Pericarditis with effusion was also seen. The diagnosis was established by isolating and identifying a dimorphic Penicillium species that produced a soluble red pigment in its mycelial form. The histopathologic features of the lymph nodes and bone marrow were similar to those of histoplasmosis capsulati. However, the yeast-like tissue form of P. marneffei divides by fission; that of Histoplasma capsulatum by budding. Treatment with amphotericin B was effective when this antifungal antibiotic was administered early in the course of the disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6476209     DOI: 10.4269/ajtmh.1984.33.637

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  29 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Penicillium marneffei infection in an AIDS patient.

Authors:  C M Hulshof; R A van Zanten; J F Sluiters; M E van der Ende; R S Samson; P E Zondervan; J H Wagenvoort
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-05       Impact factor: 3.267

Review 3.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Penicillium marneffei: types and drug susceptibility.

Authors:  P Imwidthaya; K Thipsuvan; A Chaiprasert; S Danchaivijitra; R Sutthent; J Jearanaisilavong
Journal:  Mycopathologia       Date:  2001       Impact factor: 2.574

Review 5.  Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Authors:  Cunwei Cao; Liyan Xi; Vishnu Chaturvedi
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

6.  Restriction endonuclease analysis of Penicillium marneffei.

Authors:  N Vanittanakom; C R Cooper; S Chariyalertsak; S Youngchim; K E Nelson; T Sirisanthana
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

Review 7.  Update of Penicillosis marneffei in Thailand. Review article.

Authors:  P Imwidthaya
Journal:  Mycopathologia       Date:  1994-09       Impact factor: 2.574

8.  Phylogeny and PCR identification of the human pathogenic fungus Penicillium marneffei.

Authors:  K F LoBuglio; J W Taylor
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

9.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

10.  Treatment and serological studies of an Italian case of penicilliosis marneffei contracted in Thailand by a drug addict infected with the human immunodeficiency virus.

Authors:  M A Viviani; A M Tortorano; G Rizzardini; T Quirino; L Kaufman; A A Padhye; L Ajello
Journal:  Eur J Epidemiol       Date:  1993-01       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.